\-\ Texto\\:\\ \ \(0\)\
\-\ mass\\ in\\ medial\\ left\\ supraclavicular\\ region\\ mildly\\ tender\\ to\\ palpation\\.\\ \\ no\\ fevers\\,\\ night\\ sweats\\,\\ or\\ weight\\ loss\\.\ \(0\)\
\-\ chemotherapy\\ \\(treatment\\ similar\\ to\\ that\\ for\\ acute\\ lymphocytic\\ leukemia\\)\ \(0\)\
\-\ sclerotic\\ medial\\ two\\-thirds\\ of\\ left\\ clavicle\\ with\\ cortical\\ thickening\\ and\\ permeation\\ of\\ medial\\ one\\-third\\ of\\ the\\ clavicle\\.\\ \\ large\\ associated\\ soft\\ tissue\\ mass\\ superior\\ to\\ the\\ medial\\ clavicle\\.\\ \\ no\\ cortical\\ destruction\\.\ \(0\)\
\-\ lymphoblastic\\ lymphoma\\.\ \(0\)\
\-\ fdg\\-18\\ pet\\ revealed\\ no\\ other\\ hypermetabolic\\ foci\\ in\\ the\\ chest\\,\\ abdomen\\,\\ or\\ pelvis\\.\ \(0\)\
\-\ ewing\\'s\\ sarcoma\ \(0\)\
\-\ lymphoma\ \(373\)\
\-\ osteosarcoma\ \(92\)\
\-\ chronic\\ infection\ \(10\)\
\-\ leukemia\ \(70\)\
\-\ sapho\\ syndrome\ \(0\)\
\-\ 22\\ year\\ old\\ male\\ has\\ approximately\\ 18\\-month\\ history\\ of\\ left\\ clavicular\\ head\\ enlargement\\,\\ rapidly\\ increasing\\ in\\ size\\ over\\ the\\ past\\ two\\ months\\.\\ \\ additionally\\,\\ he\\ had\\ a\\ left\\ sternoclavicular\\ dislocation\\ and\\/or\\ medial\\ left\\ clavicle\\ fracture\\ approximately\\ a\\ year\\ ago\\.\ \(0\)\
\-\ see\\ factoid\ \(116\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ clavicle\\:\\ 0\\.15008499316638008\ \(0\)\
\-\ medial\\:\\ 0\\.09903259107210334\ \(0\)\
\-\ permeation\\:\\ 0\\.0638805682896123\ \(0\)\
\-\ sapho\\:\\ 0\\.0638805682896123\ \(0\)\
\-\ 18\\-month\\:\\ 0\\.0638805682896123\ \(0\)\
\-\ leukemia\\:\\ 0\\.06354640036410411\ \(0\)\
\-\ fdg\\-18\\:\\ 0\\.05885776263338082\ \(0\)\
\-\ lymphoblastic\\:\\ 0\\.05089680401984379\ \(0\)\
\-\ sternoclavicular\\:\\ 0\\.04977977010805207\ \(0\)\
\-\ hypermetabolic\\:\\ 0\\.04650451558817484\ \(0\)\
\-\ two\\-thirds\\:\\ 0\\.0458739983636123\ \(0\)\
\-\ clavicular\\:\\ 0\\.0458739983636123\ \(0\)\
\-\ cortical\\:\\ 0\\.04514601232718568\ \(0\)\
\-\ one\\-third\\:\\ 0\\.04425701610771223\ \(0\)\
\-\ lymphocytic\\:\\ 0\\.039479873869420465\ \(0\)\
\-\ approximately\\:\\ 0\\.038316200384863525\ \(0\)\
\-\ supraclavicular\\:\\ 0\\.03811717653968902\ \(0\)\
\-\ ewing\\:\\ 0\\.03791303975007528\ \(0\)\
\-\ lymphoma\\:\\ 0\\.035394183107093996\ \(0\)\
\-\ sweats\\:\\ 0\\.035248367430326596\ \(0\)\
\-\ left\\:\\ 0\\.0346414952635114\ \(0\)\
\-\ rapidly\\:\\ 0\\.0343331955076868\ \(0\)\
\-\ pet\\:\\ 0\\.03249844263536353\ \(0\)\
\-\ osteosarcoma\\:\\ 0\\.032217902692025194\ \(0\)\
\-\ destruction\\:\\ 0\\.030582598361100787\ \(0\)\
\-\ night\\:\\ 0\\.03008753137575675\ \(0\)\
\-\ fevers\\:\\ 0\\.029434262556957493\ \(0\)\
\-\ dislocation\\:\\ 0\\.02912846288673737\ \(0\)\
\-\ sclerotic\\:\\ 0\\.027718013312954797\ \(0\)\
\-\ 22\\:\\ 0\\.02762008781174666\ \(0\)\
\-\ sarcoma\\:\\ 0\\.027571616883117697\ \(0\)\
\-\ additionally\\:\\ 0\\.026837178518912718\ \(0\)\
\-\ foci\\:\\ 0\\.026579883675022068\ \(0\)\
\-\ mildly\\:\\ 0\\.026372236894149775\ \(0\)\
\-\ and\\/or\\:\\ 0\\.026170374904997847\ \(0\)\
\-\ increasing\\:\\ 0\\.025379075687860225\ \(0\)\
\-\ tender\\:\\ 0\\.025133412269920503\ \(0\)\
\-\ enlargement\\:\\ 0\\.0245693362788775\ \(0\)\
\-\ similar\\:\\ 0\\.024287584195223828\ \(0\)\
\-\ ago\\:\\ 0\\.023048759570994556\ \(0\)\
\-\ pelvis\\:\\ 0\\.022500662366606004\ \(0\)\
\-\ weight\\:\\ 0\\.022195259312614967\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.022195259312614967\ \(0\)\
\-\ factoid\\:\\ 0\\.021706054301551717\ \(0\)\
\-\ thickening\\:\\ 0\\.02099003311371994\ \(0\)\
\-\ size\\:\\ 0\\.020759970082454865\ \(0\)\
\-\ palpation\\:\\ 0\\.02066622521991342\ \(0\)\
\-\ revealed\\:\\ 0\\.019872999201928213\ \(0\)\
\-\ superior\\:\\ 0\\.01977350505111733\ \(0\)\
\-\ past\\:\\ 0\\.019675358492365465\ \(0\)\
\-\ no\\:\\ 0\\.018705307623995696\ \(0\)\
\-\ see\\:\\ 0\\.018479834863976728\ \(0\)\
\-\ abdomen\\:\\ 0\\.01834336422388186\ \(0\)\
\-\ infection\\:\\ 0\\.018000120101976862\ \(0\)\
\-\ loss\\:\\ 0\\.017974378061365506\ \(0\)\
\-\ two\\:\\ 0\\.017734284330550767\ \(0\)\
\-\ syndrome\\:\\ 0\\.017709467947352474\ \(0\)\
\-\ head\\:\\ 0\\.017562328337492\ \(0\)\
\-\ region\\:\\ 0\\.017489863965502266\ \(0\)\
\-\ chronic\\:\\ 0\\.01744195386164493\ \(0\)\
\-\ he\\:\\ 0\\.017276719869804488\ \(0\)\
\-\ mass\\:\\ 0\\.017224072564457456\ \(0\)\
\-\ months\\:\\ 0\\.016912618077464255\ \(0\)\
\-\ fracture\\:\\ 0\\.016326625581686804\ \(0\)\
\-\ over\\:\\ 0\\.015765526015506976\ \(0\)\
\-\ acute\\:\\ 0\\.015288980645699241\ \(0\)\
\-\ soft\\:\\ 0\\.015079179449228623\ \(0\)\
\-\ chest\\:\\ 0\\.014816876812011005\ \(0\)\
\-\ tissue\\:\\ 0\\.014676965133714448\ \(0\)\
\-\ associated\\:\\ 0\\.014612047550055811\ \(0\)\
\-\ or\\:\\ 0\\.014514822448749385\ \(0\)\
\-\ other\\:\\ 0\\.014272743106539483\ \(0\)\
\-\ year\\:\\ 0\\.013856598105404561\ \(0\)\
\-\ \\'s\\:\\ 0\\.013652511727297428\ \(0\)\
\-\ large\\:\\ 0\\.013540162549500578\ \(0\)\
\-\ had\\:\\ 0\\.01336123057420803\ \(0\)\
\-\ treatment\\:\\ 0\\.012533456228991935\ \(0\)\
\-\ \\,\\:\\ 0\\.011770002848577711\ \(0\)\
\-\ has\\:\\ 0\\.011628260655755637\ \(0\)\
\-\ male\\:\\ 0\\.011197141578894733\ \(0\)\
\-\ that\\:\\ 0\\.010695512525788575\ \(0\)\
\-\ to\\:\\ 0\\.009284089313977962\ \(0\)\
\-\ in\\:\\ 0\\.009160809350875107\ \(0\)\
\-\ history\\:\\ 0\\.008552279258746982\ \(0\)\
\-\ old\\:\\ 0\\.006340105774364164\ \(0\)\
\-\ a\\:\\ 0\\.005747823214762337\ \(0\)\
\-\ for\\:\\ 0\\.00528339238146895\ \(0\)\
\-\ \\(\\:\\ 0\\.005234505262636671\ \(0\)\
\-\ \\)\\:\\ 0\\.005170562986328298\ \(0\)\
\-\ the\\:\\ 0\\.004007225643583356\ \(0\)\
\-\ of\\:\\ 0\\.0033769217622605344\ \(0\)\
\-\ \\.\\:\\ 0\\.002315187136783453\ \(0\)\
\-\ and\\:\\ 0\\.0013044130850160757\ \(0\)\
\-\ with\\:\\ 0\\.0008478563484774619\ \(0\)\
